We subsequently found that overexpression of RBM14 significantly reversed the inhibitory effects of silencing SLC35F2 on PCa cell invasion, suggesting that SLC35F2 may regulate cisplatin resistance of PCa cells by modulating RBM14. This evidence concerns the gene SLC35F2 and posterior cortical atrophy.